Could a simple 14-day heart monitor patch prevent strokes in at-risk seniors?
NCT ID NCT06953778
First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time
Summary
This study investigates whether screening older veterans (age 65 and older) who have a higher risk of atrial fibrillation—a condition where the heart beats irregularly—can reduce their chances of stroke, heart failure, or death. Participants selected for screening wear a small, waterproof patch (Zio XT) that records their heart rhythm for up to 14 days. The results are shared with their doctors, who may then prescribe blood thinners if atrial fibrillation is detected. The study compares outcomes between those screened and those receiving usual care to see if early detection makes a difference.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Zio XT Patch (wearable heart monitor)
What this could lead to
If successful, this could show that widespread screening for hidden atrial fibrillation in older adults reduces strokes and saves lives.
What could go wrong
Screening may detect harmless irregularities, leading to unnecessary treatment and bleeding risks. The trial is large but observational in design, so results may not prove cause and effect.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
VA Palo Alto Health Care System, Palo Alto, CA
Palo Alto, California, 94304-1207, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact